177 related articles for article (PubMed ID: 22588468)
1. Integrating bioinformatics and clinicopathological research of gastrointestinal stromal tumors: identification of aurora kinase A as a poor risk marker.
Yen CC; Yeh CN; Cheng CT; Jung SM; Huang SC; Chang TW; Jan YY; Tzeng CH; Chao TC; Chen YY; Yang CY; Ho CL; Fletcher JA
Ann Surg Oncol; 2012 Oct; 19(11):3491-9. PubMed ID: 22588468
[TBL] [Abstract][Full Text] [Related]
2. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.
Joensuu H; Vehtari A; Riihimäki J; Nishida T; Steigen SE; Brabec P; Plank L; Nilsson B; Cirilli C; Braconi C; Bordoni A; Magnusson MK; Linke Z; Sufliarsky J; Federico M; Jonasson JG; Dei Tos AP; Rutkowski P
Lancet Oncol; 2012 Mar; 13(3):265-74. PubMed ID: 22153892
[TBL] [Abstract][Full Text] [Related]
3. Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified Armed Forces Institute of Pathology risk criteria.
Goh BK; Chow PK; Yap WM; Kesavan SM; Song IC; Paul PG; Ooi BS; Chung YF; Wong WK
Ann Surg Oncol; 2008 Aug; 15(8):2153-63. PubMed ID: 18546045
[TBL] [Abstract][Full Text] [Related]
4. Mitotic checkpoints and chromosome instability are strong predictors of clinical outcome in gastrointestinal stromal tumors.
Lagarde P; Pérot G; Kauffmann A; Brulard C; Dapremont V; Hostein I; Neuville A; Wozniak A; Sciot R; Schöffski P; Aurias A; Coindre JM; Debiec-Rychter M; Chibon F
Clin Cancer Res; 2012 Feb; 18(3):826-38. PubMed ID: 22167411
[TBL] [Abstract][Full Text] [Related]
5. Subgroups of patients with very large gastrointestinal stromal tumors with distinct prognoses: a multicenter study.
Wada N; Kurokawa Y; Nishida T; Takahashi T; Toyokawa T; Kusanagi H; Hirota S; Tsujinaka T; Mori M; Doki Y
J Surg Oncol; 2014 Feb; 109(2):67-70. PubMed ID: 24155204
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour - the impact of tumour rupture on patient outcomes.
Rutkowski P; Bylina E; Wozniak A; Nowecki ZI; Osuch C; Matlok M; Switaj T; Michej W; Wroński M; Głuszek S; Kroc J; Nasierowska-Guttmejer A; Joensuu H
Eur J Surg Oncol; 2011 Oct; 37(10):890-6. PubMed ID: 21737227
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle proteins predict recurrence in stage II and III colon cancer.
Belt EJ; Brosens RP; Delis-van Diemen PM; Bril H; Tijssen M; van Essen DF; Heymans MW; Beliën JA; Stockmann HB; Meijer S; Meijer GA
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S682-92. PubMed ID: 22311118
[TBL] [Abstract][Full Text] [Related]
8. Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection.
Guérin A; Sasane M; Keir CH; Gauthier G; Macalalad AR; Wu EQ; Conley AP
JAMA Oncol; 2015 Sep; 1(6):797-805. PubMed ID: 26204106
[TBL] [Abstract][Full Text] [Related]
9. Survival analysis of patients with duodenal gastrointestinal stromal tumors.
Miki Y; Kurokawa Y; Hirao M; Fujitani K; Iwasa Y; Mano M; Nakamori S; Tsujinaka T
J Clin Gastroenterol; 2010 Feb; 44(2):97-101. PubMed ID: 19809358
[TBL] [Abstract][Full Text] [Related]
10. Aurora kinases as prognostic biomarkers in ovarian carcinoma.
Mendiola M; Barriuso J; Mariño-Enríquez A; Redondo A; Domínguez-Cáceres A; Hernández-Cortés G; Pérez-Fernández E; Sánchez-Navarro I; Vara JA; Suárez A; Espinosa E; González-Barón M; Palacios J; Hardisson D
Hum Pathol; 2009 May; 40(5):631-8. PubMed ID: 19157502
[TBL] [Abstract][Full Text] [Related]
11. Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor.
Rutkowski P; Nowecki ZI; Michej W; Debiec-Rychter M; Woźniak A; Limon J; Siedlecki J; Grzesiakowska U; Kakol M; Osuch C; Polkowski M; Głuszek S; Zurawski Z; Ruka W
Ann Surg Oncol; 2007 Jul; 14(7):2018-27. PubMed ID: 17473953
[TBL] [Abstract][Full Text] [Related]
12. SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis.
Wang CJ; Zhang ZZ; Xu J; Wang M; Zhao WY; Tu L; Zhuang C; Liu Q; Shen YY; Cao H; Zhang ZG
World J Gastroenterol; 2015 Jul; 21(27):8398-407. PubMed ID: 26217092
[TBL] [Abstract][Full Text] [Related]
13. "Pediatric-type" gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior.
Rege TA; Wagner AJ; Corless CL; Heinrich MC; Hornick JL
Am J Surg Pathol; 2011 Apr; 35(4):495-504. PubMed ID: 21358303
[TBL] [Abstract][Full Text] [Related]
14. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
[TBL] [Abstract][Full Text] [Related]
15. Identification of aurora kinase A as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumors.
Yeh CN; Yen CC; Chen YY; Cheng CT; Huang SC; Chang TW; Yao FY; Lin YC; Wen YS; Chiang KC; Chen JS; Yeh TS; Tzeng CH; Chao TC; Fletcher JA
Oncotarget; 2014 Jun; 5(12):4071-86. PubMed ID: 24901229
[TBL] [Abstract][Full Text] [Related]
16. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).
Martín J; Poveda A; Llombart-Bosch A; Ramos R; López-Guerrero JA; García del Muro J; Maurel J; Calabuig S; Gutierrez A; González de Sande JL; Martínez J; De Juan A; Laínez N; Losa F; Alija V; Escudero P; Casado A; García P; Blanco R; Buesa JM;
J Clin Oncol; 2005 Sep; 23(25):6190-8. PubMed ID: 16135486
[TBL] [Abstract][Full Text] [Related]
17. Aurora kinase A is superior to Ki67 as a prognostic indicator of survival in neuroblastoma.
Ramani P; Nash R; Rogers CA
Histopathology; 2015 Feb; 66(3):370-9. PubMed ID: 25297850
[TBL] [Abstract][Full Text] [Related]
18. [Primary, non-metastatic gastrointestinal stromal tumour surgery: results of the GRISK study].
Artigas Raventós V; López Pousa A; Ortega Medina L; Díaz de Liaño Argüelles A; Fernández Hernández JÁ; Lucena de la Poza JL
Cir Esp; 2013 Feb; 91(2):96-102. PubMed ID: 22748847
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
[TBL] [Abstract][Full Text] [Related]
20. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
